Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daruka Mahadevan

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Investigational New Drugs|January 17, 2022
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencingGabriel Roman Souza, Ahmed Abdalla, Sukeshi Arora, et al.
Expert Opinion on Investigational Drugs|July 27, 2017
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumorsHani M Babiker, Ali McBride, Laurence S Cooke, et al.
The Journal of Biological Chemistry|August 10, 2005
A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2)Xiaohong Zhang, Nikhil V Shirahatti, Daruka Mahadevan, et al.
Expert Opinion on Investigational Drugs|April 4, 2018
Ublituximab for the treatment of CD20 positive B-cell malignanciesHani M Babiker, Ashley E Glode, Laurence S Cooke, et al.
Molecular Cancer Therapeutics|February 5, 2024
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging TreatmentsPatrick J Conway, Jonathan Dao, Dmytro Kovalskyy, et al.
Archives of Biochemistry and Biophysics|August 18, 2004
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activityEmmanuelle J Meuillet, Daruka Mahadevan, Margareta Berggren, et al.
Leukemia Research|July 27, 2014
Genetic and cytokine changes associated with symptomatic stages of CLLAmit Agarwal, Lawrence Cooke, Christopher Riley, et al.
Cancers|November 13, 2021
Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma PatientsChristopher Morrison, Eric Weterings, Daruka Mahadevan, et al.
Oncotarget|October 28, 2015
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancerWenqing Qi, Carla Morales, Laurence S Cooke, et al.
Radiation Oncology (London, England)|December 24, 2009
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cellsJames W Welsh, Daruka Mahadevan, Ron Ellsworth, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Investigational New Drugs|January 17, 2022
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencingGabriel Roman Souza, Ahmed Abdalla, Sukeshi Arora, et al.
Expert Opinion on Investigational Drugs|July 27, 2017
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumorsHani M Babiker, Ali McBride, Laurence S Cooke, et al.
The Journal of Biological Chemistry|August 10, 2005
A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2)Xiaohong Zhang, Nikhil V Shirahatti, Daruka Mahadevan, et al.
Expert Opinion on Investigational Drugs|April 4, 2018
Ublituximab for the treatment of CD20 positive B-cell malignanciesHani M Babiker, Ashley E Glode, Laurence S Cooke, et al.
Molecular Cancer Therapeutics|February 5, 2024
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging TreatmentsPatrick J Conway, Jonathan Dao, Dmytro Kovalskyy, et al.
Archives of Biochemistry and Biophysics|August 18, 2004
Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activityEmmanuelle J Meuillet, Daruka Mahadevan, Margareta Berggren, et al.
Leukemia Research|July 27, 2014
Genetic and cytokine changes associated with symptomatic stages of CLLAmit Agarwal, Lawrence Cooke, Christopher Riley, et al.
Cancers|November 13, 2021
Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma PatientsChristopher Morrison, Eric Weterings, Daruka Mahadevan, et al.
Oncotarget|October 28, 2015
Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancerWenqing Qi, Carla Morales, Laurence S Cooke, et al.
Radiation Oncology (London, England)|December 24, 2009
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cellsJames W Welsh, Daruka Mahadevan, Ron Ellsworth, et al.
Pageof 13